The WHO Expert Committee on Biological Standardization (ECBS) was established in 1947 to provide detailed recommendations and guidelines for the manufacturing, licensing and control of blood products and related in vitro diagnostic tests, biotechnology products and vaccines along with the establishment of WHO Biological Reference Materials. The ECBS meets on an annual basis and reports directly to the Executive Board, the executive arm of the World Health Assembly.
Members of the Expert Committee are scientists from National Regulatory Agencies, academia, research institutes and public health bodies. The decisions and recommendation of the Committee are based entirely on scientific principles and considerations of public health.
Written guidelines and recommendations submitted to the ECBS are drafted through a consultative process during which WHO brings together experts in the topic from around the world. Reference materials are established through scientific studies involving participation of a large number of laboratories worldwide.
Call for comments
2nd round public consultation: comments to be received not later than 25 September 2026.
2nd round public consultation: comments to be received not later than 19 June 2026.
Technical Report Series (TRS)
All TRS →Eightieth meeting held using a hybrid format in which Committee members and the WHO Secretariat met in person in Geneva from 7 to 11 October 2024 with...
The seventy-ninth meeting of the WHO Expert Committee on Biological Standardization was held virtually from 11 to 14 March 2024. The meeting was opened...
Proceedings of the ECBS meetings
ECBS OCTOBER 2025 – BS DOCUMENTS